Goldman Sachs analyst Jamie Perse maintained a Hold rating on Enhabit, Inc (EHAB – Research Report) on August 10. The company’s shares closed last Friday at $11.50.
Perse covers the Healthcare sector, focusing on stocks such as Tenet Healthcare, Universal Health, and Agilon Health. According to TipRanks, Perse has an average return of 3.1% and a 58.62% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for Enhabit, Inc with a $13.80 average price target, which is a 20.00% upside from current levels. In a report released on August 9, Credit Suisse also assigned a Hold rating to the stock with a $15.00 price target.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $16.99 and a one-year low of $10.51. Currently, Enhabit, Inc has an average volume of 701K.
Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of EHAB in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Enhabit Inc provides home health and hospice services in the United States. It offers care where patients prefer it: in their homes. It operates business in two segments: home health and hospice. Its home health agencies provide a comprehensive range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services.
Read More on EHAB:
